Financiere des Professionnels Fonds d investissement inc. Takes Position in Waters Corporation $WAT

by · The Markets Daily

Financiere des Professionnels Fonds d investissement inc. bought a new position in shares of Waters Corporation (NYSE:WAT – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,847 shares of the medical instruments supplier’s stock, valued at approximately $1,753,000.

Several other hedge funds have also recently bought and sold shares of WAT. Vanguard Group Inc. grew its stake in Waters by 1.9% during the second quarter. Vanguard Group Inc. now owns 7,410,763 shares of the medical instruments supplier’s stock worth $2,586,653,000 after buying an additional 138,511 shares during the period. Alliancebernstein L.P. lifted its holdings in shares of Waters by 31.0% during the 2nd quarter. Alliancebernstein L.P. now owns 4,021,358 shares of the medical instruments supplier’s stock valued at $1,403,615,000 after acquiring an additional 950,687 shares in the last quarter. State Street Corp lifted its holdings in shares of Waters by 1.4% during the 2nd quarter. State Street Corp now owns 2,676,198 shares of the medical instruments supplier’s stock valued at $934,100,000 after acquiring an additional 37,763 shares in the last quarter. Geode Capital Management LLC boosted its position in Waters by 2.8% during the 2nd quarter. Geode Capital Management LLC now owns 1,552,399 shares of the medical instruments supplier’s stock worth $539,606,000 after purchasing an additional 42,202 shares during the period. Finally, Norges Bank acquired a new stake in Waters in the 2nd quarter valued at $266,384,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Wells Fargo & Company boosted their price objective on Waters from $385.00 to $415.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. TD Cowen upped their price target on Waters from $345.00 to $390.00 and gave the stock a “hold” rating in a report on Wednesday, November 5th. Cowen reaffirmed a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Waters from $300.00 to $325.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $392.19.

Get Our Latest Report on Waters

Waters Trading Up 0.6%

Shares of WAT opened at $381.97 on Friday. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The stock has a 50-day moving average price of $381.61 and a 200 day moving average price of $337.11. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.08 and a current ratio of 1.53. The company has a market capitalization of $22.75 billion, a P/E ratio of 35.11, a P/E/G ratio of 3.19 and a beta of 1.16.

Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The company had revenue of $608.55 million for the quarter. Waters had a return on equity of 36.59% and a net margin of 20.89%. Sell-side analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

About Waters

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).